Genetically altered fields as origin of locally recurrent head and neck cancer: A retrospective study

Clinical Cancer Research

Volumn 10, Issue 11, 2004, Pages 3607-3613

  Tabor, Maarten P ^a   Brakenhoff, Ruud H ^a   Ruijter Schippers, Henrique J ^a   Kummer, J Alain ^a   Leemans, C René ^a   Braakhuis, Boudewijn J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; MALE; MEDICAL DECISION MAKING; MICROSATELLITE MARKER; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 2542584017     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0632     Document Type: Article

References (25)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
2. Vikram B. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 1984;110:564-5.
3. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003;32:30-4.
4. Leemans CR, Tiwari R, Nauta JJ, Van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer (Phila) 1994;73:187-90.
5. Braakhuis BJM, Tabor MP, Leemans CR, et al. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002;24:198-206.
6. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst (Bethesda) 1999;91: 1113-24.
7. Partridge M, Li SR, Pateromichelakis S, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000;6:2718-25.
8. Hittelman WN. Genetic instability in epithelial tissues at risk for cancer. Ann NY Acad Sci 2001;952:1-12.
9. Tabor MP, Brakenhoff RH, van Houten VMM, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001;7:1523-32.
10. van Houten VMM, Leemans CR, Kummer JA, et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer 2004;10:3614-20.
11. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002;161:1051-60.
12. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
13. Gollin SM. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 2001;23:238-53.
14. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
15. Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science (Wash DC) 253:1991;253:49-53.
16. Nees M, Homann N, Discher H, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 1993;53:4189-96.
17. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
18. van Houten VM, Tabor MP, van den Brekel MW, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002;198:476-86.
19. Tabor MP, Van Houten VMM, Kummer JA, et al. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene. Genes Chromosomes Cancer 2002;33:168-77.
20. Califano J, Leong PL, Koch WM, et al. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin Cancer Res 1999;5:1862-7.
21. Tabor MP, Braakhuis BJM, Van Der Wal JE, et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol 2003;199:354-60.
22. Sudbo J, Kildal W, Risberg B, et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344: 1270-8.
23. Partridge M, Pateromichelakis S, Phillips E, et al. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 2000;60:3893-8.
24. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000;6:357-62.
25. Sabichi AL, Demierre MF, Hawk ET, Lerman CE, Lippman SM. Frontiers in cancer prevention research. Cancer Res 2003;63:5649-55.